XML 70 R63.htm IDEA: XBRL DOCUMENT v3.25.4
Segment Reporting - Schedule of Significant Segment Expenses (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Segment Reporting [Abstract]    
Personnel related costs $ 13,544 $ 23,936
Research and development expenses 6,795 14,346
Clinical trial expenses 4,325 11,285
General and administrative expenses 7,062 8,952
Facilities expenses 6,529 7,734
Stock-based compensation expense 2,782 7,407
Depreciation and other segment expenses (Note A) 1,291 2,266
Total segment expenses 42,328 75,926
Restructuring charges 1,480 3,343
Impairment charges 0 1,469
Total segment and operating expenses $ 43,808 $ 80,738